National Health Investors/$NHI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About National Health Investors
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
Ticker
$NHI
Sector
Primary listing
NYSE
Employees
30
Headquarters
Website
NHI Metrics
BasicAdvanced
$3.6B
23.85
$3.14
0.79
$3.60
4.81%
Price and volume
Market cap
$3.6B
Beta
0.79
52-week high
$80.56
52-week low
$65.13
Average daily volume
218K
Dividend rate
$3.60
Financial strength
Current ratio
0.369
Quick ratio
0.348
Long term debt to equity
58.027
Total debt to equity
74.724
Dividend payout ratio (TTM)
112.99%
Interest coverage (TTM)
3.29%
Profitability
EBITDA (TTM)
271.243
Gross margin (TTM)
97.13%
Net profit margin (TTM)
40.77%
Operating margin (TTM)
55.82%
Revenue per employee (TTM)
$11,690,000
Management effectiveness
Return on assets (TTM)
4.73%
Return on equity (TTM)
10.25%
Valuation
Price to earnings (TTM)
23.854
Price to revenue (TTM)
9.66
Price to book
2.4
Price to tangible book (TTM)
2.4
Price to free cash flow (TTM)
16.248
Free cash flow yield (TTM)
6.15%
Free cash flow per share (TTM)
4.606
Dividend yield (TTM)
4.81%
Forward dividend yield
4.81%
Growth
Revenue change (TTM)
7.21%
Earnings per share change (TTM)
6.77%
3-year revenue growth (CAGR)
8.37%
10-year revenue growth (CAGR)
5.70%
3-year earnings per share growth (CAGR)
28.74%
10-year earnings per share growth (CAGR)
-0.14%
3-year dividend per share growth (CAGR)
-0.71%
10-year dividend per share growth (CAGR)
1.06%
What the Analysts think about NHI
Analyst ratings (Buy, Hold, Sell) for National Health Investors stock.
Bulls say / Bears say
Net operating income in NHI’s Senior Housing Operating Portfolio (SHOP) climbed 29.4% year-over-year to $3.8 million in Q2 2025, driven by higher occupancy and revenue per room, showcasing strong operational results in its fastest-growing segment (ACCESS Newswire).
As of June 30, 2025, NHI had over $750 million in liquidity and a net debt to adjusted EBITDA ratio of 3.9x, under its 4.0x–5.0x target range, reflecting a solid balance sheet that supports ongoing acquisitions and opportunistic investments (ACCESS Newswire).
NHI's acquisition pipeline remains strong, with about $129.9 million in board-approved LOIs at an 8.0% average initial yield and an additional $343 million in investment opportunities under review, setting the stage for continued accretive growth (ACCESS Newswire).
Activist investor Land & Buildings has launched a proxy fight to replace two board members, citing concerns that NHI’s master lease with its largest tenant, National Healthcare Corp., is below market, highlighting governance and tenant-concentration risks (WSJ).
In Q2 2025, NHI reduced its full-year NAREIT FFO guidance to $4.46–$4.50 per diluted share from $4.64–$4.70, indicating potential margin pressures or slower earnings growth (ACCESS Newswire).
NHI anticipates an $8.8 million reduction in rental income and a $12.1 million non-cash write-off of straight-line rent receivables in Q3 2025, due to transitioning properties leased to Discovery into its SHOP segment, which may temporarily lower cash flows (ACCESS Newswire).
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
NHI Financial Performance
Revenues and expenses
NHI Earnings Performance
Company profitability
NHI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for National Health Investors stock?
National Health Investors (NHI) has a market cap of $3.6B as of October 22, 2025.
What is the P/E ratio for National Health Investors stock?
The price to earnings (P/E) ratio for National Health Investors (NHI) stock is 23.85 as of October 22, 2025.
Does National Health Investors stock pay dividends?
Yes, the National Health Investors (NHI) stock pays dividends to shareholders. As of October 22, 2025, the dividend rate is $3.6 and the yield is 4.81%. National Health Investors has a payout ratio of 112.99% on a trailing twelve-month basis.
When is the next National Health Investors dividend payment date?
The next National Health Investors (NHI) dividend payment is scheduled for October 31, 2025.
What is the beta indicator for National Health Investors?
National Health Investors (NHI) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.